Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Articles online first > Minerva Endocrinologica 2016 Jun 15

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA ENDOCRINOLOGICA

Rivista sulle Malattie del Sistema Endocrino


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118


eTOC

 

Minerva Endocrinologica 2016 Jun 15

lingua: Inglese

The possible impact of Advanced Glycation End products on pregnancy outcome in women with Diabetes Mellitus type 1

Magdalena PERTYNSKA-MARCZEWSKA 1, Katarzyna CYPRYK 2

1 Independent Consultant-Gynecology and Obstetrics, United Kingdom, New Malden, UK; 2 Diabetology and Metabolic Diseases Department, Medical University of Lodz, Lodz, Poland


PDF  


Diabetes mellitus (DM) is a group of metabolic disorders of carbohydrate metabolism in which glucose is underutilized, resulting in hyperglycemia. Reproductive impairment in poorly controlled T1DM results from a combined effect of insulin deficiency and hyperglycemia that disrupt the functioning of metabolic signals participating in the regulation of the reproductive system. Good metabolic control as a result of intensive insulin therapy has a great impact on the fertility and childbearing possibilities in the T1DM females. Advanced glycation end products (AGEs) are formed by nonenzymatic modification of proteins, lipids, and nucleic acids by glucose. The formation and accumulation of AGEs are known to progress at an accelerated rate in diabetes. AGEs either act on the pro-inflammatory cell surface receptors called RAGE or bind to the circulating anti-inflammatory sRAGE that prevents activation of cell-surface RAGE by AGEs and other proinflammatory ligands. Pregnancy has been found to induce a significant increase in RAGE protein levels in both myometrium and omental vasculature. This review will focus on the role of AGEs and RAGE in pregnancy complicated by DM type 1 as well as ways to reduce the rate of congenital malformations in the offspring of diabetic type 1 women.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

m_pertynska@yahoo.com